| Â | All HPV1 | Genital HPV2 | Cutaneous-HPV3 |
|---|
| Â | Case4 | Control | Odds Ratio (95% CI) | Case4 | Control | Odds Ratio (95% CI) | Case4 | Control | Odds Ratio (95% CI) |
|---|
HIV seronegative
| 45% (10/22) | 32% (6/19) | 1.8 (0.4–7.9) | 36% (8/22) | 32% (6/19) | 1.2 (0.3–5.5) | 27% (6/22) | 0% (0/19) | ∞ (1.8–∞) |
HIV seropositive
| 48% (25/52) | 50% (5/10) | 0.9 (0.2–4.3) | 40% (21/52) | 50% (5/10) | 0.8 (0.2–3.8) | 21% (11/52) | 10% (1/10) | 2.2 (0.2–52) |
TOTAL
| 47% (38/81) | 38% (11/29) | 1.5 (0.6–3.8) | 38% (31/81) | 38% (11/29) | 1.0 (0.4–2.7) | 22% (18/81) | 3% (1/29) | 8.0 (1.0–169) |
- 1. More than one HPV type was identified in tissue from 19 cases and four controls
- 2. Genital HPV types investigated: 6, 11, 16, 18, 31, 33–35, 39, 40, 42–45, 51–54, 56, 58, 59, 66, 68, 70, 74. Genital HPV types identified: 6, 11, 16, 18, 31, 33, 35, 44, 51, 52, 66, plus two unclassifiable; high risk genital types were identified in 13 cases (types 16 [eight people], 51 and 66 [in one person] 18, 35, 51 and 52 [one person each]) and in three controls (types 31 and 33 [two people]); HPV 11 was most frequently detected (22 cases and 10 controls)
- 3. Cutaneous HPV types investigated: 5, 8, 9, 12, 14, 15, 17, 19–25, 36–38, 47, 49, 75, 76, 80, 92, 93, 96. Cutaneous HPV types identified: 5, 8, 14, 17, 19, 23, 36, 37, 80, plus 9 unclassifiable; HPV 14 was identified in three cases and types 8, 17 and 23 were found in two people each
- 4. Among cases, 7 had unknown HIV serostatus
